Showing results (1021-1030 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|October 10, 2021
Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta-analysisLucas Lauder, Tiago V Pereira, Markus C Degenhardt, et al.
European Journal of Heart Failure|July 27, 2022
Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Muthiah Vaduganathan, Alexander Peikert, et al.
European Journal of Heart Failure|July 19, 2022
Clinical effect of obesity on N-terminal pro-B-type natriuretic peptide cut-off concentrations for the diagnosis of acute heart failureNikola Kozhuharov, Jasmin Martin, Desiree Wussler, et al.
European Journal of Heart Failure|July 19, 2022
Prognostic significance of obstructive coronary artery disease in patients admitted with acute decompensated heart failure: the ARIC study community surveillanceZainali S Chunawala, Arman Qamar, Sameer Arora, et al.
European Journal of Heart Failure|July 20, 2022
Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM-HFpEF)Cecilia Linde, Marcin Grabowski, Piotr Ponikowski, et al.
European Journal of Heart Failure|July 8, 2010
The vitamin D system: a crosstalk between the heart and kidneyMario Cozzolino, Markus Ketteler, Daniel Zehnder
European Journal of Heart Failure|July 1, 2010
Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivoIrma Kuipers, Jiang Li, Inge Vreeswijk-Baudoin, et al.
European Journal of Heart Failure|May 25, 2010
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysisEdward J Davies, Tiffany Moxham, Karen Rees, et al.
European Journal of Heart Failure|October 16, 2010
Assessment of a novel device-based diagnostic algorithm to monitor patient status in moderate-to-severe heart failure: rationale and design of the CLEPSYDRA studyAngelo Auricchio, Josep Brugada, Kenneth A Ellenbogen, et al.
European Journal of Heart Failure|October 16, 2010
Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failureOlav R de Peuter, Patrick C Souverein, Olaf H Klungel, et al.
Pageof 398